Operational Research in the context of HIV/AIDS, TB and Malaria control efforts from the perspective and experience of the Global Fund Serge Xueref John.

Slides:



Advertisements
Similar presentations
Health Systemwide Effects of the Global Fund in Benin and Ethiopia XV International AIDS Conference Bangkok July 12, 2004 Owen Smith, Abt Associates Inc.,
Advertisements

Framework for Operations and Implementation Research in Health
Presented at the ECOSOC 2012 Development Cooperation Forum 1 st High-level Symposium Bamako, Mali 5-6 May 2011 by Timothy Lubanga, Assistant Commissioner.
Armand Racine Consultant Chemicals Branch
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
Elizabeth Lule Manager ACTafrica The World Banks response to HIV/AIDS in Africa: MAP High Level Dialogue on Maximizing Synergies between Health Systems.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Standards and Trade Development Facility (STDF) A joint initiative in SPS capacity building and technical cooperation OIE Global Conference on Veterinary.
EU – ACP PROGRAMME FOR SCIENCE AND TECHNOLOGY INNOVATIONS AND CAPACITY BUILDING (PSTICB) 9 ACP RPR 61.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
The Global Fund support for Tuberculosis control STOP TB Symposium 3 December 2009, Cancun Prof. Rifat Atun and Dr Mohamed Aziz.
Global Fund Investments in Harm Reduction Washington, July 2012 Global Fund Investments for People Who Inject Drugs 23 July 2012 Professor Jeffrey V. Lazarus.
PEPFAR’s Approach to Maximize Efficiency, Effectiveness and Impact
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Stepping up the Pace Together Dynamic Partnerships Across Community, Academic and Policy Sectors Kevin Miles - Manager of Health Programmes.
GLOBAL FUND CORE PRESENTATION SET © Introduction (March 2011) GLOBAL FUND EAA Meeting Chaing Mai 22 MARCH 2011.
Global Poverty Action Fund Community Partnership Window Funding Seminar January 2014 Global Poverty Action Fund Community Partnership Window Funding Seminar.
Development Effectiveness in a world of targeted aid: the contribution of the Global Fund Dr. Viviana Mangiaterra Senior Coordinator, RMNCH and HSS Technical,
Informing Policy Through Research: The Ghana ABBA Experience Prof John Gyapong & Dr Ato Selby Research & Development Division Ghana Health Service.
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
How to Achieve Impact: Health Systems Strengthening | 16 June |1 | Global Fund New Funding Model – How to Achieve Impact: Health Systems Strengthening.
Global Health Program Guiding Principles April 2002.
Malawi: Challenges and Opportunities – Enhancing Strategic Collaboration for more Effective Programs Edith Mkawa, Principal Secretary for HIV/AIDS and.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Clermont-Ferrand, 11 May, 2011 Performance based funding Global Fund to fight AIDS, Tuberculosis and Malaria – progress and challenges Kirsi Viisainen,
Partners in Impact: Innovative Partnerships to fight disease HEI 2008 Daniel Low-Beer, Director Performance, The Global Fund to Fight AIDS, TB and malaria.
The Global Fund to Fight AIDS, Tuberculosis and Malaria: Results and Innovation in Development Cooperation for Health Silvia Ferazzi Manager, Donor Governments.
Treatment Optimization in Latin America and the Caribbean: How can the GF contribute?
Managing Risk and Overcoming Health Systems Bottlenecks in Haiti Emerging Lessons Jessica Faieta - Senior Country-Director, UNDP/Haiti & Dr Joelle Deas.
 Critical Enablers for HIV, TB & Malaria Responses UNDP & Global Fund informal session 30 th meeting of the Global Fund Board Dr Mandeep Dhaliwal United.
Total health ODA commitments, US$ Billions.
The Global Fund- structure, function and evolution February 18, 2008.
Analysis of Global Fund Support for Health Systems Strengthening Emily Trautner Geneva, Switzerland October 1, 2010.
AMFm Overview and Case Management Observations RBM Case Management Working Group (CMWG)
Suzanne Ehlers, Mercedes Mas de Xaxas, and Felicity Daly RHSC, London/ June 5, 2009 Leveraging Monies for HIV Integration and Prevention.
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
The Rising Prevalence of NCDs: Implications for Health Financing and Policy Charles Holmes, MD, MPH Office of the U.S. Global AIDS Coordinator Department.
Vertical Health Funds and Aid Effectiveness by Dr Eddie Addai Director Policy Planning Monitoring and Evaluation Ministry of Health, Ghana.
Embassy of Sweden, Lusaka Working together for greater impact: Sweden’s collaboration with the Southern African Development Community (SADC) Francis Mangani.
Green Climate Fund TC Geneva, 9 September 2011 Enhanced Direct Access – The approach of the Global Fund. Katja Roll External Relations and Partnerships.
Advancing UNAIDS support to empowering young people to protect themselves from HIV Consultation, New York, October 2009.
The Global Fund and Southern Africa A review of the structures and grants in southern Africa.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
Global Advocacy Working Group Second report back.
Global Fund Grants To SOTA Countries NO YR1 ALL Yrs TIER 113 $91 mil $461mil TIER 22 (5) $70 mil $443 mil _________________________________________________________________________.
External Relations and Partnerships Harmonization and Coordination Experiences of the Global Fund.
Introduction to OR/IR: purpose and definitions Jane Kengeya-Kayondo, WHO/TDR.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
HIV/AIDS A MAJOR DEVELOPMENT CONCERN FOR THE AFRICAN DEVELOPMENT BANK March 2008.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
Global Fund: Contributions to the Global Health Workforce 2 – 3 February 2012 Irish Forum for Global Health Conference.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
Richard Escritt, Director – Coordination of Community Actions DG Research, European Commission “The development of the ERA: Experiences from FP6 and reflections.
Fifteenth Board Meeting Geneva, April 2007 Partners in Impact Results Report Global Fund Board Meeting Geneva, April 2007.
Critical Program Movement: Integration of STD Prevention with Other Programs Kevin Fenton, MD, PhD, FFPH Director National Center for HIV/AIDS, Viral Hepatitis,
Delivering Global Goals in human settlements and city regions by 2030 with data partnerships #roadmap rd May 2016 WMO, Geneva Stephen Passmore Head.
Global Fund Work on HIV/SRH Linkages 09 March 2015 Olga Bornemisza New York, USA IAWG Meeting on HIV/SRH Linkages.
Important terminology
Outline The Global Fund Strategy emphasizes the Key Populations
ILO Programme on HIV and AIDS and the world of work,
An Overview of the Global Fund and its Architecture
Funding stigma reduction for key populations: innovation and actions
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
Yelena Shevchenko Director of Strategic Planning and
Presentation transcript:

Operational Research in the context of HIV/AIDS, TB and Malaria control efforts from the perspective and experience of the Global Fund Serge Xueref John Puvimanasinghe Jean-Paul Moatti Edward Addai Monitoring, Evaluation & Learning Unit The Global Fund, Geneva

I.The Global Fund: mandate & portfolio review II.Operational Research in GF grants: status & the way ahead III.Conclusion: m e OR

The Global Fund (GF) has a mandate to raise and disburse substantial new funds in a transparent manner to achieve sustained impact on HIV/AIDS, TB, and malaria Raise it Spend it Prove it Financing instrument -Country Ownership -Performance-based funding Introduction

$6.6 billion disbursed, 562 grants in 136 countries 58% of total funds approved (by TRP) are for grants in sub-Saharan Africa 61% for AIDS; 14% for TB; 25% for Malaria GF Portfolio overview: As of 31st October, 2008

35% of approved financing is for key health systems components Innovative cross-cutting HSS funding: –$186 million approved in Round 7 –$ 290 million recommended by TRP in Round 8 (health workforce, information systems, supply chain management, community service delivery) Global Fund supports workforce capacity: 96% of grants have a training component GF Portfolio overview (2): Health systems strengthening

GF-supported programs: Acceleration of scale up

OR in GF grants Scaling up programs to fight AIDS, TB & malaria offers a unique opportunity to experiment alternative ways of delivering key health care services and prevention interventions

I.The Global Fund: mandate & portfolio review II.Operational Research in GF grants: status & the way ahead III.Conclusion: mORe

OR in GF Grants The Global Fund encourages the inclusion of OR in the control programs it supports. Programs are encouraged to spend 5-10% of their grant budget on monitoring and evaluation (M&E), which could include spending on relevant OR.

OR in the GF Grants Definition* of OR: Any research that produces practically-usable knowledge (evidence, findings, information, etc) which can improve program implementation (effectiveness, efficiency, quality, access, scale-up, sustainability) regardless of the type of research (design, methodology, approach) falls within the boundaries of OR. * from the Framework for OR/IR in health and disease control programs (TDR/WHO/USAID/UNAIDS/WB/TGF)

Overview of OR in Global Fund Grants Global Fund Round Number of Approved Proposals (At date of Analysis) Number and Percentage of Grants with OR Component Average budget for OR (per proposal) / Percentage of Total Proposed Budget Round (19%)400,000 USD 2.6% Round (52%)434,000 USD 4.4% Round (58%)360,000 USD 2.5%

Words from the GF Exec. Director With a few exceptions, operational research that really guides and informs implementation is still under-represented at this conference. Too often, investments worth many millions of dollars are being made in the absence of good data, and too often we fail to learn from and share all our experience in scaling up AIDS programs. The AIDS field has always been innovative, unafraid to criticize and challenge. It now needs to be much more creative in fostering collaboration between science and implementation, so that research becomes an integral part of all programs. Similarly, we must also do more to link science and policy. Prof. Michel Kazatchkine, Mexico AIDS Conference, August 2008

GF goal and objectives Goal: scale-up of OR in GF grants Driving Principles: –Respect Country Ownership –Foster Partnerships –Reach Consensus, being not GF specific –Transparently share data Objectives: –To develop and implement a joint OR Framework –To facilitate the building of local capacity in OR –To develop a GF OR information system

I.The Global Fund: mandate & portfolio review II.Operational research in GF grants: status & the way ahead III.Conclusion: mORe

mORe - OR embedded into Programs to improve quality and/or quantity of services - Part of the M&E funds (5-10% of total grant) Monitoring Learning Evaluating Conclusion

Role of Countries/Partners Countries to include OR in GF grants –GF supports/encourages OR –Develop and submit OR proposals within GF applications and/or reallocate within existing grants (collaboration with the FPM) Partners to support countries in OR –Partners to support OR (protocol writing, capacity building…) GF to facilitate scaling-up of high quality OR

Merci Thank you